AIkido Pharma Inc (AIKI)

[Finditdotcom]

News Out AIKI: Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

Currently in Human Phase 2 Trials for Treatment of Prostate Cancer
New York 2/1/2021 8:00:00 AM
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Two Million Dollar Convertible Promissory Note Purchase Agreement with Convergent Therapeutics, Inc., securing an early investment in Convergent. Convergent has exclusive rights to technology related to next generation radiopharmaceutical therapy for prostate cancer that is covered by multiple issued U.S. and foreign patents.


https://www.findit.com/aikido-pharma/news/1813161/aikido-pharma-secures-early-interest-in-next-generation-radiotherapy